先天性淋巴细胞
矽肺
群(周期表)
医学
病理
淋巴系统
免疫学
细胞生物学
生物
先天免疫系统
物理
免疫系统
量子力学
作者
Y. He,Fan Yang,Lin Yang,Haoyang Yuan,Yichuan You,Y Q Chen,Xiulin Wu,Hui Min,Jie Chen,Chao Li
标识
DOI:10.1038/s41467-024-54174-5
摘要
Crystalline silica (CS) particle exposure leads to silicosis which is characterized as progressive fibrosis. Fibroblasts are vital effector cells in fibrogenesis. Emerging studies have identified immune sentinel roles for fibroblasts in chronic disease, while their immune-modulatory roles in silicosis remain unclear. Herein, we show that group 2 innate lymphoid cell (ILC2) conversion to ILC1s is closely involved in silicosis progression, which is mediated by activated fibroblasts via interleukin (IL)-18. Mechanistically, Notch3 signaling in mechanics-activated fibroblasts modulates IL-18 production via caspase 1 activity. The mouse-specific Notch3 knockout in fibroblasts retards pulmonary fibrosis progression that is linked to attenuated ILC conversion. Our results indicate that activated fibroblasts in silicotic lungs are regulators of ILC2-ILC1 conversion, associated with silicosis progression via the Notch3-IL-18 signaling axis. This finding broadens our understanding of immune-modulatory mechanisms in silicosis, and indicates potential therapeutic targets for lung fibrotic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI